GlassScriptPhysician profile
Matthew B Higgs
NPI 1588828800
$8,481.34
in general payments reported to CMS, 2019-2025
43 companies · $2,137 in 2025
The $2,137 reported for 2025 was more than what 95% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $840 · 2020: $878 · 2021: $1,499 · 2022: $1,060 · 2023: $825 · 2024: $1,243 · 2025: $2,137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,880 · Honoraria: $1,000 · Travel and Lodging: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,879.89 |
| Honoraria | $1,000.00 |
| Travel and Lodging | $325.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,748.45 | 2021-2024 | Triathlon, Mako, Crossflow |
| Brixton Biosciences, INC. | $1,145.66 | 2024-2025 | Neural Ice |
| Horizon Therapeutics Plc | $1,110.50 | 2019-2023 | Krystexxa |
| Amgen INC. | $656.21 | 2024-2025 | Krystexxa |
| Smith+Nephew, INC. | $597.34 | 2025 | Q-Fix, Bioinductive Implant With Arthroscopic Delivery System - Medium, Acufex |
| Bioventus LLC | $468.69 | 2020-2025 | Exogen Ultrasound Bone Healing System, Durolane, Supartz Fx Sodium Hyaluronate |
| Si-Bone, INC. | $310.55 | 2020-2021 | |
| Abbott Laboratories | $283.43 | 2019-2024 | Proclaim, Eterna |
| Radius Health, INC. | $177.96 | 2020-2024 | Tymlos |
| Anika Therapeutics, INC. | $156.03 | 2022 | |
| Pacira Therapeutics, INC. | $153.94 | 2019-2021 | |
| Relievant Medsystems, INC. | $147.17 | 2021 | |
| Sanara Medtech INC. | $142.50 | 2022 | |
| Depuy Synthes Sales INC. | $139.02 | 2019-2025 | Orthovisc, Monovisc |
| Sanofi-Aventis U.S. LLC | $117.09 | 2019-2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $100.70 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $94.79 | 2022-2025 | Exparel, Iovera, Zilretta |
| Medinc of Texas | $93.82 | 2023-2025 | |
| Painteq LLC | $80.76 | 2024 | Painteq |
| Nevro Corp. | $76.51 | 2020 | |
| Nalu Medical, INC. | $70.35 | 2022 | |
| Sonex Health, INC. | $64.23 | 2024 | Sx-One Microknife |
| Fidia Pharma USA INC. | $64.13 | 2023-2025 | Hymovis, Triluron |
| Assertio Therapeutics, INC. | $61.53 | 2020 | |
| Zimmer Biomet Holdings, INC. | $56.13 | 2019-2024 | Gel-One Cross-Linked Hyaluronate |
| Flowonix Medical Incorporated | $48.09 | 2019 | |
| Boston Scientific Corporation | $39.76 | 2022 | |
| Kci USA, INC. | $37.32 | 2021 | |
| Ermi LLC | $31.48 | 2020 | |
| Ossur Americas, INC. | $27.50 | 2024 | Miami J |
| Davol INC. | $27.40 | 2022 | |
| Fisher & Paykel Healthcare INC | $22.75 | 2025 | Fisher & Paykel Healthcare |
| Heron Therapeutics, INC. | $19.99 | 2023 | Zynrelef |
| Lilly USA, LLC | $18.21 | 2024 | Zepbound |
| Ethicon US, LLC | $17.80 | 2024 | Ethicon, Vistaseal |
| Vericel Corporation | $16.74 | 2024 | Maci |
| Ibsa Pharma INC. | $16.68 | 2024 | Tirosint, Licart |
| Tactile Systems Technology INC | $16.17 | 2019 | |
| Mdd US Operations, LLC | $12.86 | 2019 | |
| Hydrocision, INC. | $11.10 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Higgs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.